1246610-71-8 Usage
Uses
Used in Pharmaceutical Synthesis:
1-(2-cyanobenzyl)-3-methylurea is used as a key intermediate in the pharmaceutical industry for the synthesis of various biologically active compounds. Its unique structure, which includes the cyanobenzyl group, allows for the creation of a diverse range of pharmaceuticals with potential therapeutic applications.
Used in Agrochemical Development:
In the agrochemical industry, 1-(2-cyanobenzyl)-3-methylurea is employed as a starting material for the development of new agrochemicals. Its structural properties make it a valuable component in the design and synthesis of compounds with pesticidal, herbicidal, or fungicidal activities.
Used in Anticancer Research:
1-(2-cyanobenzyl)-3-methylurea is used as a subject of study in the field of anticancer research. Its potential to exhibit anticancer properties makes it a valuable compound for investigating novel therapeutic approaches to cancer treatment.
Used in Antiparasitic Applications:
1-(2-cyanobenzyl)-3-methylurea is also utilized in antiparasitic research, where its potential to combat parasitic infections is explored. This application could lead to the development of new treatments for a variety of parasitic diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 1246610-71-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,6,6,1 and 0 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1246610-71:
(9*1)+(8*2)+(7*4)+(6*6)+(5*6)+(4*1)+(3*0)+(2*7)+(1*1)=138
138 % 10 = 8
So 1246610-71-8 is a valid CAS Registry Number.
1246610-71-8Relevant academic research and scientific papers
PROCESS FOR THE PREPARATION OF ALOGLIPTIN
-
Page/Page column 24-25, (2010/11/05)
The present invention is based on the discovery of a process for preparing pyrimidin- dione compounds, especially alogliptin and its derivatives, which comprises the reaction of a urea derivative of formula (VIII) with a malonic acid or its derivatives to form intermediates of formulae (VII) or (VII-A), which are subsequently converted to a compound of formula (II) upon introduction of a leaving group X. Compound (II) then reacts with an amine to form compound (I), which is optionally converted to its salts of formula (IV).
